v3 Template
V

Vigil Neuroscience

Biotechnology / Neuroscience Watertown, Mass., USA
Founded
--
Employees
--
Total Funding
$40.0M
Funding Rounds
1
Last Funding
2024-06-27

About Vigil Neuroscience

Vigil Neuroscience is a microglia-focused therapeutics company dedicated to treating rare and common neurodegenerative diseases by developing disease-modifying therapeutics that restore the vigilance of microglia, the sentinel immune cells of the brain critical for central nervous system health.

Products & Services

Therapeutic Candidates for TREM2 Activation:Designed to activate the human triggering receptor expressed on myeloid cells 2 (TREM2), a key microglial receptor protein that maintains brain health, addressing dysfunction linked to neurodegeneration.

Specialties

Microglia-focused therapeutics Precision medicine for neurodegenerative diseases TREM2 activation therapies

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series A
T: -
FT: Series A 		A: 40000000
MR: -
FA: $40 million
FAN: 40000000 		D: 2024-06-27
FD: 2024-06-27 		1 investors
Series A Latest
2024-06-27
$40.0M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Vigil Neuroscience Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Neuroscience
Locations
Watertown, Mass., USA
Watertown, Mass.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro